Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyZM336372 induces apoptosis associated with phosphorylation of GSK-3beta in pancreatic adenocarcinoma cell linesGemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategiesApoptosis: targets in pancreatic cancerNew insights into the role of nuclear factor-kB in cell growth regulationLeucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosisAugmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4Signals from within: the DNA-damage-induced NF-kappaB responseNitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signalingLate activation of stress kinases (SAPK/JNK) by genotoxins requires the DNA repair proteins DNA-PKcs and CSBPrimers on molecular pathways. The glycogen synthase kinase-3betaGlycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapyThe role of FADD in pancreatic cancer cell proliferation and drug resistanceS100P: a novel therapeutic target for cancer.Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model.Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors.Irreversible EGFR inhibitor EKB-569 targets low-LET γ-radiation-triggered rel orchestration and potentiates cell death in squamous cell carcinoma.Liguzinediol improved the heart function and inhibited myocardial cell apoptosis in rats with heart failureNuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cellsInduction of cancer cell death by isoflavone: the role of multiple signaling pathways.Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.Clusterin silencing sensitizes pancreatic cancer MIA-PaCa-2 cells to gmcitabine via regulation of NF-kB/Bcl-2 signaling.Sensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor κB kinase.Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways.AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2Targeting signal transduction in pancreatic cancer treatment.Apoptotic pathways in pancreatic ductal adenocarcinomaCancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic TumorsEpigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells.MyD88 expression by CNS-resident cells is pivotal for eliciting protective immunity in brain abscesses.Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies.Interaction of stellate cells with pancreatic carcinoma cellsS100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis.Inhibition of NUCKS Facilitates Corneal Recovery Following Alkali BurnNatural and synthetic α,β-unsaturated carbonyls for NF-κB inhibition.Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy.Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-kappaB activity.
P2860
Q22299231-2ED035F9-42F4-4819-B431-B256E93A1C7BQ24600930-C1872E4E-2EEC-4488-949A-ABF8B93F04D3Q24645225-FA158E88-0881-44B5-898C-CE9DA017FF1CQ24800170-3EA876E7-7AB0-4A30-AE27-11FFC4355657Q26058119-8F610F4C-F4E0-48F4-ADFC-053B414D712CQ28200959-03B6A1EC-44ED-4477-943D-CCAC79A2AA9DQ28276508-138CCBFA-8A7C-459F-8CB1-01AF6AC3B45BQ28291658-20145634-4170-4CDC-B04A-350C423A8CEFQ28471740-97454D65-0A81-4AC8-B6C0-3BCABEFD490DQ28509902-28294347-293D-452C-9C46-896D945D1F97Q33301293-4723F010-94E1-47B5-BCAE-FCD2B8346A82Q33437264-9629D6B5-15D2-48DC-A02D-BC0658615A73Q33598878-465D947B-A74B-4A75-9501-85A928AD54E4Q33699305-E154F7C3-AA44-4EEC-8D5C-988CD8B81F1BQ33795121-C04E74A4-D008-4627-80D9-2FE34F64C646Q33924785-BE93F6DB-5A3E-498C-B599-1249F0B3C985Q34014165-9BD29921-08AB-4743-8683-A2C9CF1EBB81Q34126513-5B371088-7B60-44BC-A3A8-B77EE644C6FFQ34295053-C2BA6D8E-AA7B-40A3-A482-2E34FCCC01FEQ35486194-50B3F9D1-2A0C-4949-A128-5CFECC33D2A2Q35628160-3516AD20-A950-4339-BD0E-1C2AAA002A93Q35702968-C6270670-362B-4632-B5D8-21A4FADE4D6EQ35870045-1C762B45-34C5-47E2-A52D-29CDDB9A0CA8Q36182734-82B9B3F3-E414-4E0B-8E39-9FAC66B18E17Q36204370-390D9A0A-802F-455C-9C77-60FE2D776BC3Q36466176-638BFCFB-77A9-4A71-8957-98D9CAB86690Q36670941-AC7791DC-727C-4242-90CE-D4561AD6C6BFQ36804444-4FAB4CFF-2E27-43F2-84F4-C3352AE34E32Q36835642-4A7A8188-2E4E-46AD-81E4-55AA2A8BADC0Q37017121-59500F56-D608-4F70-BD22-BA152C0ED34BQ37179115-DFB11814-8A71-437F-A6E7-ACECD2938FB1Q37225392-CCD1B78B-0D6E-4E62-84B2-392538F5BA35Q37330181-745AA44F-CB38-43F3-B76D-38C99AD52EFBQ37334274-2252378C-167D-4EA0-8A87-9BA2F06D2712Q37354472-F9BD817D-525A-4003-8744-1AF297BB06BBQ37532942-26B87AAC-0B57-441E-8374-663792317051Q37595322-0B8E7347-B2AE-4E1A-A7D3-87D80A25C55AQ37855873-56857D0D-791F-42A9-8658-EDDE8B759D4CQ38103859-8BDD01F7-15D0-458D-81BC-0969D5F143D7Q38306010-2D22D34E-6797-4E18-B27E-ED44B73FE06B
P2860
Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Inhibition of NF-kappaB sensit ...... oposide (VP16) or doxorubicin.
@en
Inhibition of NF-kappaB sensit ...... apoptosis induced by etoposide
@nl
type
label
Inhibition of NF-kappaB sensit ...... oposide (VP16) or doxorubicin.
@en
Inhibition of NF-kappaB sensit ...... apoptosis induced by etoposide
@nl
prefLabel
Inhibition of NF-kappaB sensit ...... oposide (VP16) or doxorubicin.
@en
Inhibition of NF-kappaB sensit ...... apoptosis induced by etoposide
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of NF-kappaB sensit ...... oposide (VP16) or doxorubicin.
@en
P2093
H Kalthoff
J Vorndamm
M Breitenbroich
U R Fölsch
W E Schmidt
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204168
P407
P577
2001-02-01T00:00:00Z
P5875
P6179
1035971307